APOL1风险变异毒性取决于单倍型背景
本研究在实验系统中将G1和G2突变构建于非自然单倍型背景而非自然发生的特定G1/G2单倍型背景上,发现此举深刻改变了APOL1介导的细胞毒性。结果提示单倍型背景对APOL1毒性有关键影响,并可能普遍适用于其他遗传变异研究。
要点
- APOL1 G1/G2突变置于非自然单倍型背景会显著改变其细胞毒性。
- 自然发生的G1/G2单倍型背景对APOL1毒性有关键影响。
- 单倍型背景的影响可能推广至其他遗传变异研究。
核心结论
- APOL1风险变异G1和G2的毒性取决于其所在的单倍型背景。
研究设计与样本
- 实验系统研究,将G1和G2突变构建于非自然单倍型背景与自然G1/G2单倍型背景进行比较。
主要发现
- 在非自然单倍型背景上构建G1和G2突变深刻改变了APOL1介导的细胞毒性。
临床怎么用
- 解读APOL1风险变异时需考虑单倍型背景,避免仅凭突变本身判断毒性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Apolipoprotein L1 (APOL1) risk variants G1 and G2 are associated with high rates of kidney disease in African Americans in genetic studies. However, our understanding of APOL1 biology has lagged far behind. Here we report that engineering G1 and G2 mutations on unnatural haplotype backgrounds instead of on the specific G1 and G2 haplotype backgrounds that occur in nature profoundly alters APOL1-mediated cytotoxicity in experimental systems. Thus, in addition to helping resolve some important controversies in the APOL1 field, our demonstration of the critical influence of haplotype background may apply more generally to the study of other genetic variants that cause or predispose to human disease.
引用
- Lannon H, Shah SS, Dias L, et al. Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background. Kidney Int. 2019. PMID: 31611067. doi:10.1016/j.kint.2019.07.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。